Skip to main content
SpringerLink
Log in

Sepsis — Pathophysiologie und therapeutische Strategien

  • Conference paper
Refresher Course

Part of the book series: Refresher Course ((REFRESHER COUR,volume 25))

  • 22 Accesses

Zusammenfassung

Die verschiedenen Aspekte der Pathophysiologie bei Sepsis sind Thema unzähliger Untersuchungen und Veröffentlichungen der letzten Jahre. Obwohl viele dieser Erkenntnisse sicherlich dazu beigetragen haben, das Krankheitsbild der Sepsis besser zu verstehen, haben nur wenige dieser Einsichten in die Pathophysiologie auch neue oder verbesserte Therapieansätze hervorgebracht. So ist das Zusammenspiel und die Bedeutung der verschiedenen Mediatoren des inflammatorischen Systems heute wesentlich besser bekannt. Therapeutische Optionen, dieses auch gezielt zu beeinflussen, liegen, wie unten ausgeführt, jedoch nicht vor. Im folgenden sollen daher nur die pathophysiologischen Aspekte genannt werden, die für die unten genannten therapeutischen Strategien bei Sepsis wichtig sind.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Müller Werdan U, Prondzinsky R, Witthaut R et al. (1997) [The heart in infection and MODS (multiple organ dysfunction syndrome)] Das Herz bei Sepsis und MODS. Wien Klin Wochenschr (Suppl) 1: 3–24

    Google Scholar 

  2. Dahn MS, Lange P, Lobdell K et al. (1987) Splanchnic and total body oxygen consumption differences in septic and injured patients. Surgery 101: 69–80

    PubMed  CAS  Google Scholar 

  3. Wilmore DW, Goodwin CW, Aulick LH et al. (1980) Effect of injury and infection on visceral metabolism and circulation. Ann Surg 192: 491–504

    Article  PubMed  CAS  Google Scholar 

  4. Fiddian Green RG (1991) Role of gut in shock and resuscitation in Stoutenbeck CP, van Saene HKF (eds) Infection and the anesthetist, zz, zzzz, pp 75–99

    Google Scholar 

  5. Meakins JL, Marshall JC (1989) The gut as the motor of multiple system organ failure. In: Marston A, Bulkley GB, Fiddian Green RG (eds) Splanchnic ischemia and multiple organ failure. CV Mosby, St Louis, pp 339–348

    Google Scholar 

  6. Nelson DP, Samsel RW, Wood LD et al. (1988) Pathological supply dependence of systemic and intestinal O2 uptake during endotoxemia. J Appl Physiol 64: 2410–2419

    PubMed  CAS  Google Scholar 

  7. Steffes CP, Dahn MS, Lange MP (1994) Oxygen transport-dependent splanchnic metabolism in the sepsis syndrome. Arch Surg 129: 46–52

    PubMed  CAS  Google Scholar 

  8. Dahn MS, Mitchell RA, Lange MP et al. (1995) Hepatic metabolic response to injury and sepsis. Surgery 117: 520–530

    Article  PubMed  CAS  Google Scholar 

  9. Fong YM, Marano MA, Moldawer LL et al. (1990) The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J Clin Invest 85: 1896–1904

    Article  PubMed  CAS  Google Scholar 

  10. Meier-Hellmann A, Specht M, Hannemann L et al. (1996) Splanchnic blood flow is greater in septic shock treated with norepinephrine than in severe sepsis. Intensive Care Med 22: 1354–1359

    Article  PubMed  CAS  Google Scholar 

  11. Gottlieb ME, Sarfeh IJ, Stratton H et al. (1983) Hepatic perfusion and splanchnic oxygen consumption in patients postinjury. J Trauma 23: 836–843

    Article  PubMed  CAS  Google Scholar 

  12. Kruse JA, Carlson RW (1987) Lactate metabolism. Crit Care Clin 3: 725–746

    PubMed  CAS  Google Scholar 

  13. Wray GM, Hinds CJ (1997) Determinants of outcome from sepsis and septic shock. In: Vincent JL (ed) Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York Tokio, pp 168–179

    Google Scholar 

  14. Zeni F, Freeman B, Natanson C (1997) Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 25: 1095–1100

    Article  PubMed  CAS  Google Scholar 

  15. Connors AF, Jr., Speroff T, Dawson NV et al. (1996) The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA 276: 889–897

    Article  PubMed  Google Scholar 

  16. Spiegel T von, Wietasch G, Bursch J et al. (1996) [Cardiac output determination with transpulmonary thermodilution. An alternative to pulmonary catheterization?] HZV-Bestimmung mittels transpulmonaler Thermodilution. Eine Alternative zum Pulmonaliskatheter? Anästhesist 45: 1045–1050

    Article  Google Scholar 

  17. Shoemaker WC, Appel PL, Kram HB et al. (1988) Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 94: 1176–1186

    Article  PubMed  CAS  Google Scholar 

  18. Tuchschmidt J, Fried J, Astiz M et al. (1992) Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest 102: 216–220

    Article  PubMed  CAS  Google Scholar 

  19. Tuchschmidt J, Fried J, Swinney R et al. (1989) Early hemodynamic correlates of survival in patients with septic shock. Crit Care Med 17: 719–723

    Article  PubMed  CAS  Google Scholar 

  20. Gattinoni L, Brazzi L, Pelosi P et al. (1995) A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 333: 1025–1032

    Article  PubMed  CAS  Google Scholar 

  21. Heyland DK, Cook DJ, King D et al. (1996) Maximizing oxygen delivery in critically ill patients: a methodologic appraisal of the evidence. Crit Care Med 24: 517–524

    Article  PubMed  CAS  Google Scholar 

  22. Hayes MA, Timmins AC, Yau EH et al. (1994) Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330: 1717–1722

    Article  PubMed  CAS  Google Scholar 

  23. Bisonni RS, Holtgrave DR, Lawler F et al. (1991) Colloids vs. crystalloids in fluid resuscitation: an analysis of randomized controlled trials. J Fam Pract 32: 387–390

    PubMed  CAS  Google Scholar 

  24. Velanovich V (1989) Crystalloid vs colloid fluid resuscitation: a meta-analysis of mortality. Surgery 105: 65–71

    PubMed  CAS  Google Scholar 

  25. Roberts I (1998) Human albumin administration in critically ill patients: systematic review of randomised controlled trials. Br Med J 317: 235–240

    Google Scholar 

  26. Third European Consensus Conference in Intensive Care Medicine (1996) Tissue hypoxia: How to detect, how to correct, how to prevent. Societe de Reanimation de Langue Francaise. The American Thoracic Society. European Society of Intensive Care Medicine. Am J Respir Crit Care Med 154: 1573–1578

    Google Scholar 

  27. Marik PE, Sibbald WJ (1993) Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 269: 3024–3029

    Article  PubMed  CAS  Google Scholar 

  28. Vincent JL, Van der Linden P, Domb M et al. (1987) Dopamine compared with dobutamine in experimental septic shock: relevance to fluid administration. Anesth Analg 66: 565–571

    Article  PubMed  CAS  Google Scholar 

  29. Vincent JL, Domb M, Van der Linden P et al. (1988) Amrinone administration in endotoxin shock. Circ Shock 25: 75–83

    PubMed  CAS  Google Scholar 

  30. Silverman HJ, Tuma P (1992) Gastric tonometry in patients with sepsis. Effects of dobutamine infusions and packed red blood cell transfusions. Chest 102: 184–188

    Article  PubMed  CAS  Google Scholar 

  31. Gutierrez G, Clark C, Brown SD et al. (1994) Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients. Am J Respir Crit Care Med 150: 324–329

    PubMed  CAS  Google Scholar 

  32. Reinelt H, Radermacher P, Fischer G et al. (1997) Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock. Anesthesiology 86: 818–824

    Article  PubMed  CAS  Google Scholar 

  33. Shoemaker WC, Appel PL, Kram HB (1991) Oxygen transport measurements to evaluate tissue perfusion and titrate therapy: dobutamine and dopamine effects. Crit Care Med 19: 672–688

    Article  PubMed  CAS  Google Scholar 

  34. Desjars P, Pinaud M, Potei G et al. (1987) A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 15: 134–137

    Article  PubMed  CAS  Google Scholar 

  35. Desjars P, Pinaud M, Bugnon D et al. (1989) Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 17: 426–429

    Article  PubMed  CAS  Google Scholar 

  36. Hesselvik JF, Brodin B (1989) Low dose norepinephrine in patients with septic shock and oliguria: effects on afterload, urine flow, and oxygen transport. Crit Care Med 17: 179–180

    Article  PubMed  CAS  Google Scholar 

  37. Martin C, Eon B, Saux P et al. (1990) Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 18: 282–285

    Article  Google Scholar 

  38. Bollaert PE, Bauer P, Audibert G et al. (1990) Effects of epinephrine on hemodynamics and oxygen metabolism in dopamine-resistant septic shock. Chest 98: 949–953

    Article  PubMed  CAS  Google Scholar 

  39. Moran JL, O’Fathartaigh MS, Peisach AR et al. (1993) Epinephrine as an inotropic agent in septic shock: a dose-profile analysis. Crit Care Med 21: 70–77

    Article  PubMed  CAS  Google Scholar 

  40. Levy B, Bollaert PE, Charpentier C et al. (1997) Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: A prospective, randomized study. Intensive Care Med 23: 282–287

    Article  PubMed  CAS  Google Scholar 

  41. Day NP, Phu NH, Bethell DP et al. (1996) The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection. Lancet 348: 219–223

    Article  PubMed  CAS  Google Scholar 

  42. Meier-Hellmann A, Reinhart K, Bredle DL et al. (1997) Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med 25: 399–404

    Article  PubMed  CAS  Google Scholar 

  43. Lherm T, Troche G, Rossignol M et al. (1996) Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines. Intensive Care Med 22: 213–219

    Article  PubMed  CAS  Google Scholar 

  44. Giraud GD, MacCannell KL (1984) Decreased nutrient blood flow during dopamine-and epinephrine-induced intestinal vasodilation. J Pharmacol Exp Ther 230: 214–220

    PubMed  CAS  Google Scholar 

  45. Marik PE, Mohedin M (1994) The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 272: 1354–1357

    Article  PubMed  CAS  Google Scholar 

  46. Meier-Hellmann A, Bredle DL, Specht M et al. (1997) The effects of low dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock. Intensive Care Med 23: 31–37

    Article  PubMed  CAS  Google Scholar 

  47. Van den Berghe G, de Zegher F (1996) Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 24: 1580–1590

    Article  PubMed  Google Scholar 

  48. Sibbald WJ, Vincent JL (1995) Round table conference on clinical trials for the treatment of sepsis. Crit Care Med 23: 394–399

    Article  PubMed  CAS  Google Scholar 

  49. Cain SM, Curtis SE (1991) Systemic and regional oxygen uptake and delivery and lactate flux in endotoxic dogs infused with dopexamine. Crit Care Med 19: 1552–1560

    Article  PubMed  CAS  Google Scholar 

  50. Temmesfeld Wollbruck B, Szalay A, Mayer K et al. (1998) Abnormalities of gastric mucosal oxygenation in septic shock: Partial responsiveness to dopexamine. Am J Respir Crit Care Med 157: 1586–1592

    PubMed  CAS  Google Scholar 

  51. Tighe D, Moss R, Heywood G et al. (1995) Goal-directed therapy with dopexamine, dobutamine, and volume expansion: effects of systemic oxygen transport on hepatic ultrastructure in porcine sepsis. Crit Care Med 23: 1997–2007

    Article  PubMed  CAS  Google Scholar 

  52. Uusaro A, Ruokonen E, Takala J (1995) Gastric mucosal pH does not reflect changes in splanchnic blood flow after cardiac surgery. Br J Anaesth 74: 149–154

    Article  PubMed  CAS  Google Scholar 

  53. Meier-Hellmann A, Bredle DL, Specht M et al. (1999) Dopexamine increases splanchnic blood flow but decreases gastric mucosal ph in severe septic patients treated with dobutamine. Crit Care Med (in press)

    Google Scholar 

  54. Hannemann L, Korell R, Meier-Hellmann A et al. (1993) [Hypertonic solutions in the intensive care unit] Hypertone Losungen auf der Intensivstation. Zentralbl Chir 118: 245–249

    PubMed  CAS  Google Scholar 

  55. Kreimeier U, Frey L, Dentz J et al. (1991) Hypertonic saline dextran resuscitation during the initial phase of acute endotoxemia: effect on regional blood flow. Crit Care Med 19: 801–809

    Article  PubMed  CAS  Google Scholar 

  56. Kreimeier U, Messmer K (1991) [Use of hypertonic saline solutions in intensive care and emergency medicine-developments and perspectives] Zum Einsatz hypertoner Kochsalzlosungen in der Intensiv-und Notfallmedizin-Entwicklungen und Perspektiven. Klin Wochenschr 69(Suppl 26): 134–142

    PubMed  Google Scholar 

  57. Scheeren T, Radermacher P (1997) Prostacyclin (PGI2): new aspects of an old substance in the treatment of critically ill patients. Intensive Care Med 23: 146–158

    Article  PubMed  CAS  Google Scholar 

  58. Reinhart K, Spies CD, Meier-Hellmann A et al. (1995) N-acetylcysteine preserves oxygen consumption and gastric mucosal pH during hyperoxic ventilation. Am J Respir Crit Care Med 151: 773–779

    PubMed  CAS  Google Scholar 

  59. Spies CD, Reinhart K, Witt I et al. (1994) Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study. Crit Care Med 22: 1738–1746

    PubMed  CAS  Google Scholar 

  60. Rubanyi GM, Vanhoutte PM (1986) Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 250: H822–H827

    PubMed  CAS  Google Scholar 

  61. Harrison PM, Wendon JA, Gimson AE et al. (1991) Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 324: 1852–1857

    Article  PubMed  CAS  Google Scholar 

  62. Aruoma OI, Halliwell B, Hoey BM et al. (1989) The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 6: 593–597

    Article  PubMed  CAS  Google Scholar 

  63. Allman KG, Stoddart AP, Kennedy MM et al. (1996) L-arginine augments nitric oxide production and mesenteric blood flow in ovine endotoxemia. Am J Physiol 271: H1296–H1301

    PubMed  CAS  Google Scholar 

  64. Petros A, Bennett D, Vallance P (1991) Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338: 1557–1558

    Article  PubMed  CAS  Google Scholar 

  65. Wright CE, Rees DD, Moncada S (1992) Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 26: 48–57

    Article  PubMed  CAS  Google Scholar 

  66. Cobb JP, Natanson C, Quezado ZM et al. (1995) Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs. Am J Physiol 268: H1634–H1642

    PubMed  CAS  Google Scholar 

  67. Schneider F, Lutun P, Hasselmann M et al. (1992) Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations. Intensive Care Med 18: 309–311

    Article  CAS  Google Scholar 

  68. Brown G, Frankl D, Phang T (1996) Continuous infusion of methylene blue for septic shock. Postgrad Med J 72: 612–614

    Article  PubMed  CAS  Google Scholar 

  69. Heyland DK, Cook DJ, Guyatt GH (1993) Enteral nutrition in the critically ill patient: a critical review of the evidence. Intensive Care Med 19: 435–442

    Article  PubMed  CAS  Google Scholar 

  70. Griffiths RD, Jones C, Palmer TE (1997) Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 13: 295–302

    PubMed  CAS  Google Scholar 

  71. Roth E, Spittler A, Oehler R (1996) [Glutamine: effects on the immune system, protein balance and intestinal functions (see comments)] Glutamin: Wirkungen auf das Immunsystem, auf Eiweisshaushalt und Darmfunktionen. Wien Klin Wochenschr 108: 669–676

    PubMed  CAS  Google Scholar 

  72. Kemen M, Senkal M, Homann HH et al. (1995) Early postoperative enteral nutrition with arginine-omega-3 fatty acids and ribonucleic acid-supplemented diet vs. placebo in cancer patients: an immunologic evaluation of Impact. Crit Care Med 23: 652–659

    Article  PubMed  CAS  Google Scholar 

  73. Daly JM, Lieberman MD, Goldfine J et al. (1992) Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery 112: 56–67

    PubMed  CAS  Google Scholar 

  74. Heyland DK, Cook DJ, Guyatt GH (1994) Does the formulation of enteral feeding products influence infectious morbidity and mortality rates in the critically ill patients? A critical review of the evidence. Crit Care Med 22: 1192–1202

    Article  PubMed  CAS  Google Scholar 

  75. Bollaert PE, Charpentier C, Levy B et al. (1998) Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26: 645–650

    Article  PubMed  CAS  Google Scholar 

  76. Briegel J, Kellermann W, Forst H et al. (1994) Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The Phospholipase A2 Study Group. Clin Investig 72: 782–787

    Article  PubMed  CAS  Google Scholar 

  77. Matot I, Sprung CL (1998) Corticosteroids in septic shock: Resurrection of the last rites? Crit Care Med 26: 627–630

    Article  PubMed  CAS  Google Scholar 

  78. Grootendorst AF, van Bommel EF (1993) The role of hemofiltration in the critically-ill intensive care unit patient: present and future. Blood Purif 11: 209–223

    Article  PubMed  CAS  Google Scholar 

  79. Grootendorst AF, van Bommel EF, van Leengoed LA et al. (1993) Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care 8: 161–169

    Article  PubMed  CAS  Google Scholar 

  80. Grootendorst AF, van Bommel EF, van der Hoven B et al. (1992) High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 18: 235–240

    Article  PubMed  CAS  Google Scholar 

  81. Lee PA, Matson JR, Pryor RW et al. (1993) Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 21: 914–924

    Article  PubMed  CAS  Google Scholar 

  82. Lange R, Erhard J, Sander A et al. (1996) [Use of continuous veno-venous high volume hemofiltration (CVVHVH) in patients with multiple organ failure. Principle and applications] Der Einsatz der kontinuierlichen veno-venosen Hochvolumen-Hamofiltration (CVVHVH) bei Patienten im Multiorganversagen. Prinzip und Anwendung. Zentralbl Chir 121: 535–540

    PubMed  CAS  Google Scholar 

  83. Storck M, Hartl WH, Zimmerer E et al. (1991) Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure. Lancet 337: 452–455

    Article  PubMed  CAS  Google Scholar 

  84. Bone RC, Balk RA, Cerra FB et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644–1655

    Article  PubMed  CAS  Google Scholar 

  85. Gutierrez G, Palizas F, Doglio G et al. (1992) Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet 339: 195–199

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. A. Meier-Hellmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Brauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Bloos
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Meier-Hellmann, A., Brauer, M., Bloos, F. (1999). Sepsis — Pathophysiologie und therapeutische Strategien. In: Refresher Course. Refresher Course, vol 25. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60110-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60110-1_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-65594-7

  • Online ISBN: 978-3-642-60110-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation